Publications

Found 2 results
Filters: Author is M.A.R. Silva  [Clear All Filters]
2012
M. F. P. T. Baldez da Silva, Guimarães, V., Silva, M. A. R., Amaral, C. M. Medeiros d, Beçak, W., Stocco, R. C., Freitas, A. C., and Crovella, S., Frequency of human papillomavirus types 16, 18, 31, and 33 and sites of cervical lesions in gynecological patients from Recife, Brazil, vol. 11, pp. 462-466, 2012.
Ault KA (2006). Epidemiology and natural history of human papillomavirus infections in the female genital tract. Infect. Dis. Obstet. Gynecol. 2006: 1-5. http://dx.doi.org/10.1155/IDOG/2006/40470 Baldez da Silva MF, Chagas BS, Guimaraes V, Katz LM, et al. (2009). HPV31 and HPV33 incidence in cervical samples from women in Recife, Brazil. Genet. Mol. Res. 8: 1437-1443. http://dx.doi.org/10.4238/vol8-4gmr677 PMid:20013657 Broomall EM, Reynolds SM and Jacobson RM (2010). Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus. Postgrad. Med. 122: 121-129. http://dx.doi.org/10.3810/pgm.2010.03.2129 PMid:20203463 Castro TM, Peixoto PG, Bussoloti IF, Nascimento VX, et al. (2009). Detecção de HPV na mucosa oral e genital pela técnica PCR em mulheres com diagnóstico histopatológico positivo para HPV genital. Rev. Bras. Otorrinolaringol. 75: 167-171. http://dx.doi.org/10.1590/S0034-72992009000200002 PMid:19575099 Chaturvedi AK (2010). Beyond cervical cancer: burden of other HPV-related cancers among men and women. J. Adolesc. Health 46: S20-S26. http://dx.doi.org/10.1016/j.jadohealth.2010.01.016 PMid:20307840 Derchain SFM and Sarian LOZ (2007). Vacinas profiláticas para o HPV. Rev. Bras. Ginecol. Obstet. 29: 281-284. http://dx.doi.org/10.1590/S0100-72032007000600001 Giuliano A and Palefsky J (2009). Quadrivalent HPV Vaccine Efficacy Against Male Genital Disease and Infection. In: 25th International Papillomavirus Conference Clinical and Educational Workshop, Malmö. Karlsen F, Kalantari M, Jenkins A, Pettersen E, et al. (1996). Use of multiple PCR primer sets for optimal detection of human papillomavirus. J. Clin. Microbiol. 34: 2095-2100. PMid:8862564    PMCid:229196 Lorenzato F, Ho L, Terry G, Singer A, et al. (2000). The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int. J. Gynecol. Cancer 10: 143-150. http://dx.doi.org/10.1046/j.1525-1438.2000.00007.x PMid:11240666 Muñoz N, Bosch FX, de Sanjosé S, Herrero R, et al. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348: 518-527. http://dx.doi.org/10.1056/NEJMoa021641 PMid:12571259 Park RB and Androphy EJ (2002). Genetic analysis of high-risk E6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol. 76: 11359-11364. http://dx.doi.org/10.1128/JVI.76.22.11359-11364.2002 PMid:12388696    PMCid:136782 Rama CH, Roteli-Martins CM, Derchain SFM, Longatto-Filho A, et al. (2008a). Prevalência do HPV em mulheres rastreadas para o câncer cervical. Rev. Saúde Pública 42: 123-130. http://dx.doi.org/10.1590/S0034-89102008000100016 Rama CH, Roteli-Martins CM, Derchain SFM, Longato-Filho A, et al. (2008b). Rastreamento anterior para câncer de colo uterino em mulheres com alterações citológicas ou histológicas. Rev. Saúde Pública 42: 411-419. http://dx.doi.org/10.1590/S0034-89102008000300004 Rambout L, Hopkins L, Hutton B and Fergusson D (2007). Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials. CMAJ 177: 469-479. http://dx.doi.org/10.1503/cmaj.070948 PMid:17671238    PMCid:1950172